Details of the Drug Formulations

General Information of Drug (ID: DMGU74E)

• Drug Name: Cholecalciferol Drug Info
• Synonyms: Arachitol; Calciol; Cholecalciferolum; Colecalciferol; Colecalciferolo; Colecalciferolum; Colecalcipherol; Delsterol; Deparal; Ebivit; FeraCol; Provitamine; Provitina; Rampage; Ricketon; Trivitan; Vigorsan; Colecalciferolo [DCIT]; VITAMIN D; Duphafral D3 1000; LT00244775; NEO Dohyfral D3; Oleovitamin D3; TNP00266; VITAMIN D3 POWDER; VITAMIN_D3; Vitamin D3; Vitamin D3 emulsifiable; Activated 7-dehydrocholesterol; Cholecalciferol (D3); Cholecalciferol, D3; Colecalciferol (INN); Colecalciferolum [INN-Latin]; D3-Vicotrat; D3-Vigantol; Delta-D; Irradiated 7-dehydrocholesterol; Micro-dee; Vitamin d-3; Cholecalciferol (JP15/USP); Cholecalciferol [USAN:BAN:JAN]; Delta-D (TN); Vitinc Dan-Dee-3; Vi-de-3-hydrosol; (+)-Vitamin D3; (3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol; (3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol; (5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol; (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol; 25(OH)D; 7-Dehydrocholesterol activated; 7-Dehydrocholesterol, Activated; 7-Dehydrocholesterol, irradiated; 7-Dehydrocholestrol, activated; 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol; 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol; 9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(beta.)-ol; 9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol

Indication

Disease Entry	ICD 11	Status	REF
Adult acute monocytic leukemia		Approved	[1]
Exostosis		Approved	[1]
Hypercalcaemia	5B91.0	Approved	[1]
Hyperlipidemia	5C80.Z	Approved	[1]
Hypoparathyroidism	5A50	Approved	[1]
Osteoporosis	FB83.0	Approved	[1]
Pleural tuberculosis		Approved	[1]
Primary hyperparathyroidism		Approved	[1]
Rickets	5B57	Approved	[1]
Schizoaffective disorder	6A21	Approved	[1]
Vitamin D deficiency	5B57	Approved	[2]
Vitamin D-dependent rickets		Approved	[1]
Vitamin deficiency	5B55-5B71	Approved	[1]
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 3	[3]
Autosomal dominant hypocalcemia	5A50.0Y	Investigative	[1]

• Therapeutic Class: Vitamins
• Cross-matching ID:
  PubChem CID: 5280795
  ChEBI ID: CHEBI:28940
  CAS Number: 67-97-0
  TTD ID: D0K5WS
  ACDINA ID: D00128

Full List of Drug Formulations Containing This Drug

Cholecalciferol 10000 unt capsule

Company	Formulation ID	FDA Description
Medecor Pharma	F04110	D&c yellow no. 10; Fd&c yellow no. 6; Glycerin; Titanium dioxide; Water; Polysorbate 80; Silicon dioxide; Gelatin; Soybean oil

Cholecalciferol 50000 unt capsule

Company	Formulation ID	FDA Description
Medecor Pharma	F04113	D&c yellow no. 10; Fd&c yellow no. 6; Glycerin; Titanium dioxide; Water; Polysorbate 80; Silicon dioxide; Gelatin; Soybean oil

Cholecalciferol 25000 unt capsule

Company	Formulation ID	FDA Description
Medecor Pharma	F04112	Ferric oxide yellow; Glycerin; Titanium dioxide; Water; Polysorbate 80; Silicon dioxide; Carrageenan; Hydroxypropyl corn starch (5% substitution by weight); Sodium phosphate, dibasic, anhydrous; Soybean oil; Tocopherol

Cholecalciferol 50000 unt tablet

Company	Formulation ID	FDA Description
Pharmin	F04114	Magnesium stearate; Silicon dioxide; Hypromelloses; Powdered cellulose

References

• [1] Cholecalciferol FDA Label
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2747).
• [3] Cholecalciferol to Improve the Outcomes of COVID-19 Patients (CARED)